Results 151 to 160 of about 1,218,748 (261)
RNA profiling of circulating extracellular vesicles (EVs) from blood samples of men undergoing prostate biopsy identifies transcripts associated with clinically significant prostate cancer. Integrative analysis with public tumor datasets links EV‐derived gene signatures to tumor stage and progression‐free survival, highlighting CASP3, XRCC2, and RIT1 ...
Stefan Werner +14 more
wiley +1 more source
Missing value imputation in proximity extension assay-based targeted proteomics data. [PDF]
Lenz M +14 more
europepmc +1 more source
Intratumour heterogeneity complicates precision management of advanced endometrial cancer. Circulating tumor DNA (ctDNA) offers a minimally invasive strategy to capture tumor evolution and therapeutic resistance. Here, we compare tumor‐agnostic NGS with tumor‐informed ddPCR, outlining their relative sensitivity, concordance, and clinical implications ...
Carlos Casas‐Arozamena +15 more
wiley +1 more source
Missing value imputation for > 2 MeV electron fluxes in geostationary orbit based on GA-RF model. [PDF]
Fang M +5 more
europepmc +1 more source
NAguideR: performing and prioritizing missing value imputations for consistent bottom-up proteomic analyses. [PDF]
Wang S +5 more
europepmc +1 more source
A urine‐based digital PCR assay targeting two hotspot TERT promoter variants detected bladder cancer with high sensitivity and no false positives in this case–control cohort. The streamlined AbsoluteQ workflow outperformed Sanger sequencing and supports non‐invasive molecular testing for bladder cancer detection.
Anna Nykel +12 more
wiley +1 more source
New adjusted missing value imputation in multiple regression with simple random sampling and rank set sampling methods. [PDF]
Sinsomboonthong J, Sinsomboonthong S.
europepmc +1 more source
A Multi-directional Approach for Missing Value Estimation in Multivariate Time Series Clinical Data. [PDF]
Xu X +11 more
europepmc +1 more source
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska +13 more
wiley +1 more source
Missing Value Imputation of Wireless Sensor Data for Environmental Monitoring. [PDF]
Decorte T +6 more
europepmc +1 more source

